We are live on ! Find out more
VMD icon

Viemed Healthcare

9.48 USD
-0.27
2.77%
At close Updated Oct 16, 4:00 PM EDT
Pre-market
After hours
9.48
0.00
0%
1 day
-2.77%
5 days
0.64%
1 month
6.04%
3 months
-21.59%
6 months
-0.94%
Year to date
31.3%
1 year
38.39%
5 years
66.9%
10 years
35.04%
 

About: Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.

Employees: 1,382

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 22.2%
Neutral 66.7%
Negative 11.1%
Neutral
Zacks Investment Research
10 days ago
Do Options Traders Know Something About Viemed Stock We Don't?
Investors need to pay close attention to VMD stock based on the movements in the options market lately.
Do Options Traders Know Something About Viemed Stock We Don't?
Neutral
Newsfile Corp
11 days ago
Viemed Healthcare, Inc. to Present at the 20th Annual LD Micro Main Event
Lafayette, Louisiana--(Newsfile Corp. - October 6, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Viemed Healthcare, Inc. is scheduled to present on Tuesday, October 20, 2026 at 12:30 PM PT.
Viemed Healthcare, Inc. to Present at the 20th Annual LD Micro Main Event
Positive
Seeking Alpha
19 days ago
Viemed Healthcare: Improving Capital Efficiency Creates A Strong Buy Opportunity
Viemed Healthcare (VMD) is evolving from a capital-intensive respiratory equipment company into a diversified, capital-light home healthcare provider. VMD's expansion into sleep, resupply, and women's health segments is driving robust revenue growth while reducing capital intensity and supporting free cash flow acceleration. Despite margin compression from the new business mix, VMD needs only 0.5% annual free cash flow growth to justify its current valuation, offering a strong margin of safety.
Viemed Healthcare: Improving Capital Efficiency Creates A Strong Buy Opportunity
Positive
MarketBeat
1 month ago
Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands
Viemed Healthcare NASDAQ: VMD outlined its growth strategy, product diversification and capital allocation priorities at the Midwest IDEAS Conference, emphasizing its focus on providing in-home care for patients with complex respiratory conditions.
Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands
Neutral
Seeking Alpha
2 months ago
Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript
Neutral
MarketBeat
2 months ago
Viemed Healthcare Q2 Earnings Call Highlights
Viemed Healthcare NASDAQ: VMD reported record second-quarter revenue as growth in its ventilator business resumed under the updated Medicare coverage framework and newer service lines expanded.
Viemed Healthcare Q2 Earnings Call Highlights
Negative
Zacks Investment Research
2 months ago
Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates
Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.08 per share a year ago.
Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates
Neutral
Accesswire
2 months ago
Viemed Healthcare Announces Second Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / August 3, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and six months ended June 30, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2026 were $78.1 million, setting a Company record, representing an increase of $15.0 million, or 23.9%, compared with the prior-year quarter and an increase of approximately 3.6% sequentially.
Viemed Healthcare Announces Second Quarter 2026 Financial Results
Neutral
Accesswire
2 months ago
Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Second Quarter 2026 Earnings Conference Call on Tuesday, August 4, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=peVp8cbE Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
Neutral
The Motley Fool
4 months ago
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
Surgery Partners operates a massive nationwide network of outpatient surgical facilities and hospitals. Viemed Healthcare is a high-growth specialist focusing on home-based respiratory care and disease management.
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
Price charts implemented using Lightweight Charts™